← Back
$TRDA All transactions

Entrada Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$32K

Shares

2,500

Price

$13

Filed

Apr 2

Insider

Name

WENTWORTH KORY JAMES

Title

Chief Financial Officer

CIK

0001725663

Roles

Officer

Transaction Details

Transaction Date

2026-04-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

119,010

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2025.

Filing Info

Accession No.

0001725663-26-000005

Form Type

4

Issuer CIK

0001689375

WENTWORTH KORY JAMES's History

Date Ticker Type Value
2026-04-01 TRDA $32K
2025-11-21 TRDA $89K
2025-09-02 TRDA F $9K

Other Insiders at TRDA (90d)

No other insider activity at this issuer in the last 90 days.